Bronstein M D, Musolino N R, Benabou S, Marino R
Division of Functional Neurosurgery, Hospital das Clinicas, University of Sao Paulo Medical School, Brazil.
Surg Neurol. 1989 Nov;32(5):346-9. doi: 10.1016/0090-3019(89)90137-7.
Two patients harboring invasive macroprolactinomas, on treatment with bromocriptine, developed cerebrospinal fluid rhinorrhea 16 and 17 months after the beginning of the medical therapy. Neither patient had previously been submitted to surgery or radiotherapy. The fistulae were surgically corrected. Cerebrospinal fluid leakage is a well-documented complication of pituitary tumors, mainly after surgery and/or radiotherapy, but the reports of its occurrence after primary treatment with bromocriptine are rare. Therefore, the possibility of this complication must be considered, especially in patients with invasive macroprolactinomas.
两名患有侵袭性大泌乳素瘤的患者,在接受溴隐亭治疗后,分别在药物治疗开始后的16个月和17个月出现脑脊液鼻漏。两名患者此前均未接受过手术或放疗。瘘管通过手术得到了纠正。脑脊液漏是垂体肿瘤的一种有充分文献记载的并发症,主要发生在手术和/或放疗后,但关于溴隐亭初始治疗后发生这种并发症的报道很少。因此,必须考虑这种并发症的可能性,尤其是在患有侵袭性大泌乳素瘤的患者中。